Quick Answer
MADRIGAL PHARMACEUTICALS, INC. reported Total Assets of $1.26 billion for the year ending 2025.
- MADRIGAL PHARMACEUTICALS, INC. showed an increase of +20.9% in Total Assets from 2024 to 2025.
- This data is from MADRIGAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $65.62 million | Q3 2011: $53.87 million | Q1 2012: $59.84 million | Q2 2012: $47.16 million | Q3 2012: $57.61 million | Q1 2013: $93.70 million | Q2 2013: $73.92 million | Q3 2013: $56.66 million | Q1 2014: $82.18 million | Q2 2014: $115.95 million | Q3 2014: $123.66 million | Q1 2015: $79.39 million | Q2 2015: $101.54 million | Q3 2015: $91.01 million | Q1 2016: $52.97 million | Q2 2016: $44.94 million | Q3 2016: $41.51 million | Q1 2017: $40.36 million | Q2 2017: $68.07 million | Q3 2017: $62.83 million | Q1 2018: $183.48 million | Q2 2018: $491.53 million | Q3 2018: $489.55 million | Q1 2019: $479.56 million | Q2 2019: $469.82 million | Q3 2019: $456.25 million | Q1 2020: $411.46 million | Q2 2020: $388.39 million | Q3 2020: $339.62 million | Q1 2021: $309.73 million | Q2 2021: $327.96 million | Q3 2021: $304.70 million | Q1 2022: $222.66 million | Q2 2022: $216.39 million | Q3 2022: $158.64 million | Q1 2023: $332.45 million | Q2 2023: $302.46 million | Q3 2023: $237.96 million | Q1 2024: $1.08 billion | Q2 2024: $1.10 billion | Q3 2024: $1.07 billion | Q1 2025: $996.63 million | Q2 2025: $1.02 billion | Q3 2025: $1.36 billion.
- Over the full 16 years of available data (2010 to 2025), MADRIGAL PHARMACEUTICALS, INC.'s Total Assets has grown by 2,229.7%.
- Historical annual values: Fiscal year 2025: $1.26 billion | Fiscal year 2024: $1.04 billion | Fiscal year 2023: $640.55 million | Fiscal year 2022: $362.57 million | Fiscal year 2021: $273.33 million | Fiscal year 2020: $287.00 million | Fiscal year 2019: $442.06 million | Fiscal year 2018: $485.43 million | Fiscal year 2017: $192.31 million | Fiscal year 2016: $41.21 million | Fiscal year 2015: $363.6 thousand | Fiscal year 2014: $100.68 million | Fiscal year 2013: $95.20 million | Fiscal year 2012: $103.02 million | Fiscal year 2011: $42.32 million | Fiscal year 2010: $54.07 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: